Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5009.0075.55 (+1.53 %)

PREV CLOSE ( ) 4933.45

OPEN PRICE ( ) 4933.45

BID PRICE (QTY) 5007.70 (1)

OFFER PRICE (QTY) 5014.95 (11)

VOLUME 2200

TODAY'S LOW / HIGH ( )4923.40 5011.00

52 WK LOW / HIGH ( )4498.9 6440

NSE4987.0053.8 (+1.09 %)

PREV CLOSE( ) 4933.20

OPEN PRICE ( ) 4933.20

BID PRICE (QTY) 4987.30 (13)

OFFER PRICE (QTY) 4989.00 (28)

VOLUME 134148

TODAY'S LOW / HIGH( ) 4920.30 5005.00

52 WK LOW / HIGH ( )4491.65 6439.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-08 1973

Management Info

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office

Address Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022 3982 9999

Email investors@alkem.com / contact@alkem.com

Website www.alkemlabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

08Jul Alkem Laboratories informs about compl
Pursuant to Regulation 30 of the SEBI LODR Regulations, Alkem Laboratori..

18Jun Alkem Laboratories informs about chang
Alkem Laboratories has informed that Board of Directors at its meeting h..

11Jun Alkem Laboratories informs about analy
Provisions of the SEBI (Listing Obligations and Disclosure Requirements)..

20Mar Alkem Laboratories informs about analy
Alkem Laboratories has informed that with reference to relevant provisio..

18Mar Alkem Laboratories informs about analy
With reference to relevant provisions of the SEBI (Listing Obligations a..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	2769.4	22808.9
Gross Profit	2998.3	23035.4
Operating Profit	4083.8	26632.6
Net Sales	20449.4	88134.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1335.05 (16.72%)	M.Cap ( in Cr)408.14
RPG Life Sciences (BSE) 2652.60 (3.74%)	M.Cap ( in Cr)4365.97
Sanofi Cons. Health (BSE) 5215.15 (1.75%)	M.Cap ( in Cr)12030.16
Procter&Gamble Healt (BSE) 5950.00 (1.46%)	M.Cap ( in Cr)9810.23
Gland Pharma (BSE) 1964.90 (3.63%)	M.Cap ( in Cr)32314.50

Shareholding Pattern

	PROMOTERS	55.13%
	NON-INSTITUTION	16.05%
	MUTUAL FUNDS/UTI	14.97%
	FI/BANKS/INSURANCE	3.2%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Tata Nifty MidSmall...	4.49
Motilal Oswal Nifty...	4.47
ICICI Pru Pharma He...	4.01
NJ ELSS Tax Saver S...	3.58
LIC MF Healthcare F...	3.50
Nippon India Nifty ...	3.36
ICICI Pru Nifty Pha...	3.36

Risk Disclosures on Derivatives

Smart Quotes

ALKEM LABORATORIES LTD.